Advertisement
Review Article| Volume 16, ISSUE 1, P75-86, March 2023

Download started.

Ok

It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii

Published:December 13, 2022DOI:https://doi.org/10.1016/j.path.2022.09.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgical Pathology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shaco-Levy R.
        • M F.
        • Stewart C.J.R.
        WHO Classification of Female Genital Tumors: Struma ovarii. 5th ed. World Health Organization, Lyon2020 (132–22)
        • Siegel M.R.
        • Wolsky R.J.
        • Alvarez E.A.
        • et al.
        Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature.
        Arch Gynecol Obstet. 2019; 300: 1693-1707
        • Robboy S.J.
        • Shaco-Levy R.
        • Peng R.Y.
        • et al.
        Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread.
        Int J Gynecol Pathol. 2009; 28: 405-422
        • Addley S.
        • Mihai R.
        • Alazzam M.
        • et al.
        Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years.
        Arch Gynecol Obstet. 2021; 303: 863-870
        • Tan A.
        • Stewart C.J.
        • Garrett K.L.
        • et al.
        Novel BRAF and KRAS mutations in papillary thyroid carcinoma arising in struma ovarii.
        Endocr Pathol. 2015; 26: 296-301
        • Li S.
        • Yang T.
        • Xiang Y.
        • et al.
        Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.
        BMC Cancer. 2021; 21: 383
        • Khunamornpong S.
        • Settakorn J.
        • Sukpan K.
        • et al.
        Poorly differentiated thyroid carcinoma arising in struma ovarii.
        Case Rep Pathol. 2015; 2015: 826978
        • Roth L.M.
        • Karseladze A.I.
        Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
        Int J Gynecol Pathol. 2008; 27: 213-222
        • Cui Y.
        • Yao J.
        • Wang S.
        • et al.
        The clinical and pathological characteristics of malignant struma ovarii: an analysis of 144 published patients.
        Front Oncol. 2021; 11: 645156
        • Young R.H.
        • Jackson A.
        • Wells M.
        Ovarian metastasis from thyroid carcinoma 12 years after partial thyroidectomy mimicking struma ovarii: report of a case.
        Int J Gynecol Pathol. 1994; 13: 181-185
        • Yoo S.C.
        • Chang K.H.
        • Lyu M.O.
        • et al.
        Clinical characteristics of struma ovarii.
        J Gynecol Oncol. 2008; 19: 135-138
        • Shaco-Levy R.
        • Bean S.M.
        • Bentley R.C.
        • et al.
        Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread.
        Int J Gynecol Pathol. 2010; 29: 212-227
        • Zhang X.
        • Axiotis C.
        Thyroid-type carcinoma of struma ovarii.
        Arch Pathol Lab Med. 2010; 134: 786-791
        • Garg K.
        • Soslow R.A.
        • Rivera M.
        • et al.
        Histologically bland "extremely well differentiated" thyroid carcinomas arising in struma ovarii can recur and metastasize.
        Int J Gynecol Pathol. 2009; 28: 222-230
        • Roth L.M.
        • Czernobilsky B.
        • Roth D.J.
        • et al.
        Highly differentiated follicular thyroid-type carcinoma of the ovary reconsidered.
        J Clin Pathol. 2021; 74: 553-557
        • Shaco-Levy R.
        • Peng R.Y.
        • Snyder M.J.
        • et al.
        Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior.
        Arch Pathol Lab Med. 2012; 136: 172-178
        • Devaney K.
        • Snyder R.
        • Norris H.J.
        • et al.
        Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
        Int J Gynecol Pathol. 1993; 12: 333-343
        • Cancer Genome Atlas Research N.
        Integrated genomic characterization of papillary thyroid carcinoma.
        Cell. 2014; 159: 676-690
        • Tsukada T.
        • Yoshida H.
        • Ishikawa M.
        • et al.
        Malignant struma ovarii presenting with follicular carcinoma: A case report with molecular analysis.
        Gynecol Oncol Rep. 2019; 30: 100498
        • Schmidt J.
        • Derr V.
        • Heinrich M.C.
        • et al.
        BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
        Am J Surg Pathol. 2007; 31: 1337-1343
        • Poli R.
        • Scatolini M.
        • Grosso E.
        • et al.
        Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
        Endocrine. 2021; 71: 216-224
        • Boutross-Tadross O.
        • Saleh R.
        • Asa S.L.
        Follicular variant papillary thyroid carcinoma arising in struma ovarii.
        Endocr Pathol. 2007; 18: 182-186
        • Gomes-Lima C.J.
        • Nikiforov Y.E.
        • Lee W.
        • et al.
        Synchronous independent papillary thyroid carcinomas in struma ovarii and the thyroid gland with different RAS mutations.
        J Endocr Soc. 2018; 2: 944-948
        • Henderson B.B.
        • Chaubey A.
        • Roth L.M.
        • et al.
        Whole-genome and segmental homozygosity confirm errors in meiosis as etiology of struma ovarii.
        Cytogenet Genome Res. 2020; 160: 2-10
        • Goffredo P.
        • Sawka A.M.
        • Pura J.
        • et al.
        Malignant struma ovarii: a population-level analysis of a large series of 68 patients.
        Thyroid. 2015; 25: 211-215
        • Leong A.
        • Roche P.J.
        • Paliouras M.
        • et al.
        Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
        J Clin Endocrinol Metab. 2013; 98: 4599-4605
        • DeSimone C.P.
        • Lele S.M.
        • Modesitt S.C.
        Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.
        Gynecol Oncol. 2003; 89: 543-548
        • Yassa L.
        • Sadow P.
        • Marqusee E.
        Malignant struma ovarii.
        Nat Clin Pract Endocrinol Metab. 2008; 4: 469-472
        • Rose P.G.
        • Arafah B.
        • Abdul-Karim F.W.
        Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels.
        Gynecol Oncol. 1998; 70: 425-427